Concepedia

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois, Joseph Kerger, Lionel D’Hondt, Vincent Verschaeve, Jean Luc Canon, Catherine Dopchie, Jean‐Marie Vandenbulcke, Nicolas Whenham,

Annals of Oncology · 2012 · 124 citations · 44 references

DOIFull text

Open access

Concepts

References

44

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · The Lancet · 2008 · 3K citations

, , +11

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +12

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Hans von der Maase, Lisa Sengeløv, J.T. Roberts et al. · Journal of Clinical Oncology · 2005 · 1.9K citations

, , +6

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

Darcy A. Krueger, Marguerite M. Caré, Katherine Holland et al. · New England Journal of Medicine · 2010 · 1K citations · Full text

, , +13